Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)

Tao Zhang; Jingjie Li; Xiaojun Ma; Yang Yang; Wei Sun; Wangrui Jin; Lei Wang; Yuan He; Feifei Yang; Zhengfang Yi; Yingqi Hua; Mingyao Liu; Yihua Chen; Zhengdong Cai

doi:10.1016/j.ebiom.2020.102629

Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)

Tao Zhang^*
, Jingjie Li
, Xiaojun Ma
, Yang Yang
, Wei Sun
, Wangrui Jin
, Lei Wang
, Yuan He
, Feifei Yang
, Zhengfang Yi
, Yingqi Hua
, Mingyao Liu
, Yihua Chen
, Zhengdong Cai

^*Corresponding author for this work

School of Life Sciences

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

The published version of this article contained an error in Fig. 2c and f, the corrected Fig. 2 is included below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.

Original language	English
Article number	102629
Journal	eBioMedicine
Volume	52
DOIs	https://doi.org/10.1016/j.ebiom.2020.102629
State	Published - Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ebiom.2020.102629

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)'. Together they form a unique fingerprint.

Cite this

Zhang, T., Li, J., Ma, X., Yang, Y., Sun, W., Jin, W., Wang, L., He, Y., Yang, F., Yi, Z., Hua, Y., Liu, M., Chen, Y., & Cai, Z. (2020). Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003). eBioMedicine, 52, Article 102629. https://doi.org/10.1016/j.ebiom.2020.102629

@article{87935ea73f4b4ec4bd353adf4d972cbb,

title = "Corrigendum to {\textquoteleft}Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer{\textquoteright} [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)",

abstract = "The published version of this article contained an error in Fig. 2c and f, the corrected Fig. 2 is included below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.",

author = "Tao Zhang and Jingjie Li and Xiaojun Ma and Yang Yang and Wei Sun and Wangrui Jin and Lei Wang and Yuan He and Feifei Yang and Zhengfang Yi and Yingqi Hua and Mingyao Liu and Yihua Chen and Zhengdong Cai",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s)",

year = "2020",

month = feb,

doi = "10.1016/j.ebiom.2020.102629",

language = "英语",

volume = "52",

journal = "eBioMedicine",

issn = "2352-3964",

publisher = "Elsevier B.V.",

}

Zhang, T, Li, J, Ma, X, Yang, Y, Sun, W, Jin, W, Wang, L, He, Y, Yang, F, Yi, Z, Hua, Y, Liu, M, Chen, Y & Cai, Z 2020, 'Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)', eBioMedicine, vol. 52, 102629. https://doi.org/10.1016/j.ebiom.2020.102629

Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003). / Zhang, Tao; Li, Jingjie; Ma, Xiaojun et al.
In: eBioMedicine, Vol. 52, 102629, 02.2020.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)

AU - Zhang, Tao

AU - Li, Jingjie

AU - Ma, Xiaojun

AU - Yang, Yang

AU - Sun, Wei

AU - Jin, Wangrui

AU - Wang, Lei

AU - He, Yuan

AU - Yang, Feifei

AU - Yi, Zhengfang

AU - Hua, Yingqi

AU - Liu, Mingyao

AU - Chen, Yihua

AU - Cai, Zhengdong

PY - 2020/2

Y1 - 2020/2

N2 - The published version of this article contained an error in Fig. 2c and f, the corrected Fig. 2 is included below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.

AB - The published version of this article contained an error in Fig. 2c and f, the corrected Fig. 2 is included below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.

UR - https://www.scopus.com/pages/publications/85078058043

U2 - 10.1016/j.ebiom.2020.102629

DO - 10.1016/j.ebiom.2020.102629

M3 - 评论/辩论

C2 - 31972471

AN - SCOPUS:85078058043

SN - 2352-3964

VL - 52

JO - eBioMedicine

JF - eBioMedicine

M1 - 102629

ER -

Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286](S2352396418301580)(10.1016/j.ebiom.2018.05.003)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this